$NUWE

Nuwellis, Inc. reported its Q4 2025 earnings, showing a significant increase in revenue compared to the previous quarter. The company highlighted strong demand for its medical products and made positive projections for future growth. However, they also acknowledged challenges in supply chain disruptions impacting product availability. Analysts are mixed on the outlook; while some view the revenue growth positively, concerns about ongoing supply chain issues remain. The overall sentiment in the market appears cautiously optimistic, but investors should watch for updates on the supply chain situation.